clinical trial · NCT05797896
Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study
Dry Age-related Macular DegenerationGeographic AtrophyRetinal DiseaseMacular DegenerationMacular AtrophyRetinal DegenerationEye Diseases
brief summary
An observational study to investigate the natural history and evaluate biomarkers of participants with geographic atrophy secondary to age-related macular degeneration
started
Feb 7, 2023
primary completion
Jul 31, 2027
completion
Jul 31, 2027
last updated
Jun 13, 2025
detailed description
Prospective, observational study to assess the relationships between circulating levels of complement proteins measured using the Complement Precision Medicine (CPM) Platform, genetic profile and lesion progression in subjects with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD) up to a 24-month period
official title
A Multicentre, Natural History, Non-interventional Study Evaluating Biomarkers In Participants With Geographic Atrophy(GA) Secondary To Age-Related Macular Degeneration (AMD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol